Recurrent ERBB2 alterations are associated with esophageal adenocarcinoma brain metastases
Nora M. Lawson, Lingqun Ye, Chae Yun Cho, Bo Zhao, Thomas J. Mitchell, Inés Martín-Barrio, Bruno Beernaert, Archit Gupta, Matei A. Banu, Yonathan Lissanu, Sydney M. Shaffer, Hussein A. Tawbi, Jing Li, Maria Kristine Gule-Monroe, Christopher A Alvarez-Breckenridge, , Kadir Caner Akdemir
The paper identifies ERBB2 alterations as a recurrent oncogene in esophageal adenocarcinoma brain metastases and links them to monoclonal seeding and treatment response.
medRxiv · Feb 19, 2025 · PreprintGenetic & Genomic Medicine